Epidermal growth factor receptor (EGFR) enhanced expression in chemoresistant non-small-cell lung carcinoma (NSCLC) after platinum-based therapy

被引：0
|
作者：
Val, D [1 ]
Majo, J [1 ]
Rojo, F [1 ]
Felip, E [1 ]
De Torres, I [1 ]
Baselga, J [1 ]
Ramon, S [1 ]
机构：
[1] Hosp Univ Vall Hebron, Barcelona, Spain
来源：
LABORATORY INVESTIGATION | 2005年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1483
引用
收藏
页码：319A / 319A
页数：1
相关论文
共 50 条
  • [1] Epidermal growth factor receptor (EGFR) enhanced expression in chemoresistant non-small-cell lung carcinoma (NSCLC) after platinum-based therapy
    Val, D
    Majo, J
    Rojo, F
    Felip, F
    De Torres, I
    Baselga, J
    Cajal, SRY
    [J]. MODERN PATHOLOGY, 2005, 18 : 319A - 319A
  • [2] Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
    O'Leary, Connor
    Gasper, Harry
    Sahin, Katherine B.
    Tang, Ming
    Kulasinghe, Arutha
    Adams, Mark N.
    Richard, Derek J.
    O'Byrne, Ken J.
    [J]. PHARMACEUTICALS, 2020, 13 (10) : 1 - 16
  • [3] Epidermal growth factor receptor (EGFR) expression in non-small cell lung carcinoma (NSCLC) and survival
    Salimath, Shivalingaswamy
    Jayaraj, B. S.
    Mahesh, P. A.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [4] Comparison of epidermal growth factor receptor (EGFR) and downstream markers expression in samples from non-small-cell lung cancer (NSCLC) patients, at diagnosis and after progression following platinum-based chemotherapy
    Cedres, S.
    Felip, E.
    Prat, A.
    Rojo, F.
    Majo, J.
    Pallisa, E.
    de Gracia, J.
    Vilar, E.
    Parera, M.
    Baselga, J.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 245 - 245
  • [5] Epidermal Growth Factor Receptor (EGFR) Expression Levels Predict Cetuximab Activity in Non-small-cell Lung Cancer (NSCLC)
    Stroh, C.
    Staub, E.
    Friese-Hamim, M.
    Stoerkel, S.
    Amendt, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : 121 - 121
  • [6] Epidermal growth factor receptor (EGFR) expression correlation between diagnostic and post-platinum-based progression samples of non-small-cell lung cancer (NSCLC) patients
    Felip, Enriqueta
    Rojo, Federico
    Iglesias, Carmela
    Parera, Marta
    Pallisa, Ester
    Andreu, Jordi
    Majo, Joaquim
    Ramon y Cajal, Santiago
    Baselga, Jose
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 184 - 184
  • [7] Evaluation of epidermal growth factor receptor (EGFR) as a prognostic factor for survival in non-small-cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy as first-line treatment.
    Janas, M
    Bailey, LR
    Schmidt, K
    Bindslev, N
    Wolf, M
    Fandi, A
    Askaa, J
    Herbst, R
    Giaccone, G
    Johnson, DH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 622S - 622S
  • [8] Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma
    Ahn, JH
    Kim, SW
    Hong, SM
    Suh, C
    Kim, WK
    Lee, IC
    Lee, JS
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2004, 19 (04) : 529 - 535
  • [9] Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC)
    Mukohara, T
    Kudoh, S
    Yamauchi, S
    Kimura, T
    Yoshimura, N
    Kanazawa, H
    Hirata, K
    Wanibuchi, H
    Fukushima, S
    Inoue, K
    Yoshikawa, J
    [J]. LUNG CANCER, 2003, 41 (02) : 123 - 130
  • [10] Evaluation of epidermal growth factor receptor (EGFR) as a predictive marker in patients with non-small-cell lung cancer (NSCLC) receiving first-line gefitinib combined with platinum-based chemotherapy.
    Bailey, LR
    Janas, M
    Schmidt, K
    Bindslev, N
    Wolf, M
    Grous, J
    Askaa, J
    Herbst, R
    Johnson, DH
    Giaccone, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 620S - 620S
12345